News
19m
Investor's Business Daily on MSNStocks Generating Improved Relative Strength: GSK ADRRating upgraded from 66 to 73 Tuesday — a welcome improvement, but still shy of the 80 or better score you prefer to see.
Small airways disease may be evaluated with a single inspiratory CT scan using generative artificial intelligence (AI).
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Blood-based proteomic profiling of 251 inflammatory proteins in 543 patients with newly diagnosed acute myeloid leukemia (AML) identifies an eight-protein signature that enhances risk stratification.
Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the ...
1d
Pharmaceutical Technology on MSNUK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatmentThe UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...
GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger ...
China also has a near one-third stake in the Hinkley nuclear power plant in Somerset, while Hong Kong billionaire Li Ka-shing ...
China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...
U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...
The Michigan health department confirmed a measles outbreak in Montcalm County on Thursday, marking the first such occurrence ...
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results